Bovine Respiratory Disease Treatment Market Forecast Report 2018-2023Posted by Shiva on July 12th, 2019 Bovine Respiratory Disease Treatment Market Size and Growth: Bovine Respiratory Disease Treatment Market Size has been estimated at USD 44.9 million in 2019 and is projected to reach USD 124.6 million by 2024, at a CAGR of 22.4% during the forecast period from 2019 to 2024. The threat of bovine respiratory disease (BRD) has an important effect on the value of cattle in the marketplace. Bovine Respiratory Disease is the most popular and costly disease affecting the beef cattle industry. The disease which affects both lower and upper respiratory tract is referred as BRD. View full Report @https://www.marketdataforecast.com/market-reports/bovine-respiratory-disease-treatment-market/ Bovine Respiratory Disease Treatment Market Drivers and Restraints: BRD is a common term for respiratory disease in cattle caused by Variety of factors. A major cause of economic losses, BRD affects the lower respiratory tract / lungs (pneumonia) or upper respiratory tract (rhinitis, tracheid’s, bronchitis). Key factor responsible for the disease is stress. Early detection is touted as an important key to treatment success. Bovine respiratory disease (BRD) can be a costly expense for cattle producers. However, it can be avoided by making the use of vaccines. Get Sample Copy for more Professional and Technical insights @ https://www.marketdataforecast.com/market-reports/bovine-respiratory-disease-treatment-market/request-sample Detailed Segmentation of the Bovine Respiratory Disease Treatment Industry: By Type of Treatment:
Geographical Classification of Bovine Respiratory Disease Treatment Industry:
North America Region is leading the Market: North America leads the market due to greater occurrence of bovine respiratory disease. In the Asia Pacific region, China and India have greater cattle adoption and are expected to grow fast. Major Key Players Mentioned: The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A. For more information: Abhishek Shukla Sales Manager at Market Data Forecast Email: abhishek@marketdataforecast.com Tel: +1-888-702-9626 Website: https://www.marketdataforecast.com/ Like it? Share it! More by this author |